Citations

Showing 10 of 108119 citations.

Teaching NeuroImage: Pseudo–Figure-of-4 Sign
Rao, Chethan K. , Tatum, William O.

Mayo Clinic

Neurology | October 21, 2021 | Volume: 98 | Issue: 3 | Pages: No page available

10.1212/wnl.0000000000013003 | PMID 34675095 Get It

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast
Yadav, Siddhartha , Nathanson, Katherine L. , Weitzel, Jeffrey N. , Goldgar, David E. , Kraft, Peter , Gnanaolivu, Rohan D., Na, Jie , Huang, Hongyan, Boddicker, Nicholas , Larson, Nicole, Gao, Chi , Weinberg, Clarice, Vachon, Celine M. , Taylor, Jack A. , Patel, Alpa, Olson, Janet E., Lindstrom, Sara, Lacey, James V., Kurian, Allison W. , John, Esther M. , Haiman, Christopher, Auer, Paul W., Anton-Culver, Hoda, Chao, Elizabeth, Yussuf, Amal , Pesaran, Tina , Dolinsky, Jill S. , LaDuca, Holly , Hu, Chunling , Nathanson, Katherine L , Weitzel, Jeffrey N , Goldgar, David E , Kraft, Peter , Na, Jie , Boddicker, Nicholas J , Gao, Chi , Yao, Song , Vachon, Celine M. , Trentham-Dietz, Amy , Taylor, Jack A , Sandler, Dale P , Palmer, Julie R , Neuhausen, Susan L. , Martı́nez, Marı́a Elena , Kurian, Allison W , John, Esther M , Bernstein, Leslie , Ambrosone, Christine B , Karam, Rachid , Yussuf, Amal , Pesaran, Tina , Dolinsky, Jill S , Hart, Steven N , LaDuca, Holly , Polley, Eric C , Domchek, Susan M , Couch, Fergus J. , Yadav, Siddhartha , Gnanaolivu, Rohan D., Huang, Hongyan, Larson, Nicole, Weinberg, Clarice, Patel, Alpa, Olson, Janet E., Lindstrom, Sara, Lacey, James V., Haiman, Christopher, Auer, Paul W., Anton-Culver, Hoda, Chao, Elizabeth

Mayo Clinic

Journal of Clinical Oncology | October 21, 2021 | Volume: 39 | Issue: 35 | Pages: 3918-3926

10.1200/jco.21.00640 | PMID 34672684 Get It

PURPOSETo determine the contribution of germline pathogenic variants (PVs) in hereditary cancer testing panel genes to invasive lobular carcinoma (ILC) of the breast.MATERIALS AND METHODSThe study included 2,999 women with ILC from a population-based cohort and 3,796 women with ILC undergoing clinical multigene panel testing (clinical cohort). Frequencies of germline PVs in breast cancer predisposition genes ( ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, and TP53) were compared between women with ILC and unaffected female controls and between women with ILC and infiltrating ductal carcinoma (IDC).RESULTSThe frequency of PVs in breast cancer predisposition genes among women with ILC was 6.5% in the clinical cohort and 5.2% in the population-based cohort. In case-control analysis, CDH1 and BRCA2 PVs were associated with high risks of ILC (odds ratio [OR] > 4) and CHEK2, ATM, and PALB2 PVs were associated with moderate (OR = 2-4) risks. BRCA1 PVs and CHEK2 p.Ile157Thr were not associated with clinically relevant risks (OR < 2) of ILC. Compared with IDC, CDH1 PVs were > 10-fold enriched, whereas PVs in BRCA1 were substantially reduced in ILC.CONCLUSIONThe study establishes that PVs in ATM, BRCA2, CDH1, CHEK2, and PALB2 are associated with an increased risk of ILC, whereas BRCA1 PVs are not. The similar overall PV frequencies for ILC and IDC suggest that cancer histology should not influence the decision to proceed with genetic testing. Similar to IDC, multigene panel testing may be appropriate for women with ILC, but CDH1 should be specifically discussed because of low prevalence and gastric cancer risk.
Amelioration of Leigh syndrome induced by mouse blastocyst complementation with a mutant human mitochondrial ATP synthase 6
Yuan, Huijun , Bhatti, Tariq, Guy, John, Webster, Keith A. , Bhatti, Tariq, Hauswirth, William W. , Lewin, Alfred S.

Mayo Clinic

No container title available | October 21, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-963913/v1 Get It

Abstract Mutations in mitochondrial genes are primary causes of multiple inherited disorders, especially affecting tissues with high aerobic energy demands such as the eye, brain, heart, and skeletal muscles. Such mitochondrial diseases are untreatable, have poor prognoses, and relevant animal models are few. Here we microinjected into the mouse blastocyst an adeno-associated virus (AAV) that we redirected to mitochondria to deliver the mutant human adenosine triphosphate (ATP) synthase subunit 6 gene (m.8993T>G) responsible for Maternally Inherited Leigh Syndrome, a neurologic disease renowned for causing rapidly fatal encephalomyelopathy in childhood or Neuropathy, Ataxia and Retinitis Pigmentosa in adults. Mice bred over six generations exhibited hallmarks of the human disease with one or multiple systemic symptoms including early death, paralysis, hunching, vision loss and seizures. Necropsy revealed spongiform encephalopathy, retinal degeneration, and cardiomegaly. Intravenous injection of a mitochondrially directed AAV serotype 9 vector containing wild-type ATP6 after disease onset, conferred prolonged survival and reduced paralysis. When administered prior to disease onset, all treated mice survived, and visual and motor function improved. These results support further development of gene therapy strategies involving intravenous delivery of mito-targeted AAV9.
Higher levels of serum phosphorus are associated with coronary calcification post heart transplantation
Ahmad, Ali , Lerman, Lilach O. , Kushwaha, Sudhir S. , Ӧzcan, Ilke , Toya, Takumi , Corban, Michel , Nardi, Valentina , Lerman, Amir

Mayo Clinic

European Heart Journal | October 21, 2021 | Volume: 42 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehab724.2271 Get It

Abstract Background A higher serum phosphorus level, although within the normal range has been linked to coronary artery and aortic calcification in the non-transplant population. Coronary calcification is mostly associated with donor-derived lesions, and is uncommon within the first years after heart transplantation. Purpose We aimed to investigate the association of phosphorus levels with plaque calcification after heart transplantation. Methods A total of 156 patients who underwent virtual histology intravascular ultrasound (VH-IVUS) studies for cardiac allograft vasculopathy (CAV) surveillance and had fasting serum phosphorus levels &lt;4.5 mg/dL, were included in the analyses. IVUS analyses were performed in the proximal left anterior descending artery, and plaque composition of dense calcium (DC) was evaluated using VH-IVUS, and presented as percent DC of total plaque volume. The patients were separated into 3 groups according to tertiles of serum phosphorus levels. Results Mean recipient and donor ages were 54±13 and 31±14 years, respectively. Mean serum phosphorus in recipients was 3.5±0.6 mg/dL, with median time after transplantation at the IVUS studies of 6 (3,10) years. There were no significant differences in %DC between phosphorus tertiles in patients who underwent IVUS within 6 years after transplantation (p=0.11, Fig. 1A). However, beyond 6 years after transplantation, we observed an incremental association between phosphorus levels and the extent of calcification (p=0.02, Fig. 1B). In this group, serum phosphorus levels significantly correlated with %DC (standardized β=0.29, P=0.008), and this correlation remained significant after adjustment for donor age, recipient age, and eGFR (standardized β=0.26, P=0.001). Conclusion Higher serum phosphorus levels were associated with a level-dependent increase in calcified coronary artery plaque in patients starting 6 years post heart transplant. Long-term exposure to higher serum phosphorus, even within the normal range, might promote plaque calcification after heart transplantation. Funding Acknowledgement Type of funding sources: None.
A Coronavirus Disease 2019 Pandemic Pivot: Development of the American Board of Anesthesiology’s Virtual APPLIED Examination
Keegan, Mark T. , McLoughlin, Thomas M, Fiadjoe, John E. , Pisacano, Margaret M., Harman, Ann E., Patterson, Andrew J., Warner, David O. , Sun, Huaping

Mayo Clinic

Anesthesia & Analgesia | October 21, 2021 | Volume: 133 | Issue: 5 | Pages: 1331-1341

10.1213/ane.0000000000005750 | PMID 34517394 Get It

In 2020, the coronavirus disease 2019 (COVID-19) pandemic interrupted the administration of the APPLIED Examination, the final part of the American Board of Anesthesiology (ABA) staged examination system for initial certification. In response, the ABA developed, piloted, and implemented an Internet-based “virtual” form of the examination to allow administration of both components of the APPLIED Exam (Standardized Oral Examination and Objective Structured Clinical Examination) when it was impractical and unsafe for candidates and examiners to travel and have in-person interactions. This article describes the development of the ABA virtual APPLIED Examination, including its rationale, examination format, technology infrastructure, candidate communication, and examiner training. Although the logistics are formidable, we report a methodology for successfully introducing a large-scale, high-stakes, 2-element, remote examination that replicates previously validated assessments.
Overcoming Therapeutic Inertia in Type 2 Diabetes Care—Timing, Context, and Appropriateness of Treatment Intensification
McCoy, Rozalina G. , O’Connor, Patrick J.

Mayo Clinic

JAMA Network Open | October 21, 2021 | Volume: 4 | Issue: 10 | Pages: e2130926

10.1001/jamanetworkopen.2021.30926 | PMID 34673968 Get It

Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway
Nakamura, Ikuo , Asumda, Faizal Z., Moser, Catherine D., Kang, Yoo Na , Lai, Jinping , Roberts, Lewis R. , Kang, Yoo Na N, Lai, Jin-Ping, Roberts, Lewis R

Mayo Clinic

Cancers | October 21, 2021 | Volume: 13 | Issue: 21 | Pages: 5279

10.3390/cancers13215279 | PMID 34771445 Get It

Transforming growth factor-β (TGF-β) activates hepatic stellate cells (HSCs), which drive liver fibrosis via the production and deposition of extracellular matrix (ECM). We aimed to elucidate the mechanistic role of sulfatase-2 (SULF2) in liver fibrosis. To this end, we induced liver fibrosis in wild-type (WT) and SULF2 knockout (Sulf2-KO) mice (6–8 weeks-old) via bile duct ligation (BDL), intraperitoneal injection of carbon tetrachloride (CCl4) or thioacetamide (TAA). The levels of fibrosis in the liver sections were assessed via Sirius red and Masson’s trichrome staining, immunohistochemistry and immunoblotting for α-smooth muscle actin (α-SMA) and hydroxyproline. To evaluate the interaction between TGF-β and SULF2, we transfected human HSCs with scrambled control shRNA and shRNA constructs targeting SULF2 and measured α-SMA expression following treatment with TGF-β1 ligand. We show here that knockout of SULF2 significantly decreases collagen content, as well as bands of bridging fibrosis, as demonstrated by Sirius red, Masson’s trichrome and α-SMA staining after BDL, CCl4 and TAA injection in Sulf2-KO versus WT mice. In all three models of liver fibrosis, we observed significantly lower levels of hydroxyproline in the Sulf2-KO mice compared to the WT mice. HSCs with reduced levels of SULF2 failed to significantly express α-SMA and collagen type I following treatment with TGF-β1. Furthermore, SULF2 co-localizes with TGFBR3 and the in vitro knockdown of SULF2 in HSCs decreases the release of TGF-β1 from TGFBR3. Together, these data suggest that SULF2 regulates liver fibrosis via the TGF-β signaling pathway. Pharmacologic inhibition of SULF2 may represent a novel therapeutic approach to improve liver fibrosis.
Memory Support System in Spanish: A Pilot Study
Santos, Octavio A. , Rios-Rosales, Anapaula, Pedraza, Otto , Bergeron, Caroline D. , Chandler, Melanie

Mayo Clinic

Brain Sciences | October 21, 2021 | Volume: 11 | Issue: 11 | Pages: 1379

10.3390/brainsci11111379 | PMID 34827378 Get It

Subjective cognitive decline (SCD) is prevalent in the general population, particularly among Hispanic adults. SCD increases the risk of mild cognitive impairment (MCI) and dementia. While non-pharmacologic interventions are recommended to mitigate cognitive decline and preserve daily function in SCD and MCI, such interventions are not readily available for Spanish-speaking Hispanic adults with SCD. This pilot study, preregistered at clinicialtrials.gov, aimed to develop a linguistically and culturally appropriate adaptation of an existing memory compensation intervention, the Memory Support System (MSS), from English to Spanish, and to gather data to assess its impact in this population. Twenty Spanish-speaking Hispanic adults with SCD and 16 support partners were recruited. Measures of treatment adherence, daily function, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden were assessed at baseline, treatment end, and 8-week follow-up. By treatment end, participants with SCD improved their general functional status, daily activities requiring organizational skills, and depression and anxiety symptoms. Partners reported improvement in anxiety by treatment end and in caregiver burden at follow-up. The MSS was successfully translated into Spanish and readily learned by participants with SCD and their partners. The MSS in Spanish may help with daily functioning and aspects of patient and family well-being.